Clinical Trial Update: ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.

View source ↗

Summary

ALIGN is a non-randomised study evaluating injectable lenacapavir for HIV pre-exposure prevention in a PrEP decision context in Cape Town, South Africa. The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lenacapavir (lenacapavir)

Snippet

Sponsor: Desmond Tutu HIV Foundation | Conditions: HIV | Status: NOT_YET_RECRUITING